GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Gross-Profit-to-Asset %

ArcticZymes Technologies ASA (FRA:B4V) Gross-Profit-to-Asset % : 26.82% (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ArcticZymes Technologies ASA's annualized Gross Profit for the quarter that ended in Dec. 2024 was €7.82 Mil. ArcticZymes Technologies ASA's average Total Assets over the quarter that ended in Dec. 2024 was €29.14 Mil. Therefore, ArcticZymes Technologies ASA's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 26.82%.


ArcticZymes Technologies ASA Gross-Profit-to-Asset % Historical Data

The historical data trend for ArcticZymes Technologies ASA's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Gross-Profit-to-Asset % Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.75 49.96 43.07 32.76 28.48

ArcticZymes Technologies ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.12 33.60 28.80 25.82 26.82

Competitive Comparison of ArcticZymes Technologies ASA's Gross-Profit-to-Asset %

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Gross-Profit-to-Asset % falls into.


;
;

ArcticZymes Technologies ASA Gross-Profit-to-Asset % Calculation

ArcticZymes Technologies ASA's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=8.372/( (29.495+29.301)/ 2 )
=8.372/29.398
=28.48 %

ArcticZymes Technologies ASA's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=7.816/( (28.987+29.301)/ 2 )
=7.816/29.144
=26.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


ArcticZymes Technologies ASA Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines